These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16787227)

  • 21. An overview on how components of the melanocortin system respond to different high energy diets.
    van den Heuvel JK; van Rozen AJ; Adan RA; la Fleur SE
    Eur J Pharmacol; 2011 Jun; 660(1):207-12. PubMed ID: 21211524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug target discovery by pharmacogenetics: mutations in the melanocortin system and eating disorders.
    Adan RA; Vink T
    Eur Neuropsychopharmacol; 2001 Dec; 11(6):483-90. PubMed ID: 11704425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Obesity based on mutation of genes involved in energy balance].
    Hainerová I
    Cas Lek Cesk; 2007; 146(3):240-5. PubMed ID: 17419307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes.
    Iwen KA; Senyaman O; Schwartz A; Drenckhan M; Meier B; Hadaschik D; Klein J
    J Endocrinol; 2008 Mar; 196(3):465-72. PubMed ID: 18310442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive receptor activity series: endogenous inverse agonists and constitutive receptor activity in the melanocortin system.
    Adan RA
    Trends Pharmacol Sci; 2006 Apr; 27(4):183-6. PubMed ID: 16500715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanocortins in brain inflammation: the role of melanocortin receptor subtypes.
    Muceniece R; Dambrova M
    Adv Exp Med Biol; 2010; 681():61-70. PubMed ID: 21222260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. If I only had a whole brain: the importance of extrahypothalamic areas in the energy balance equation.
    Schneider JE
    Endocrinology; 2009 Dec; 150(12):5195-8. PubMed ID: 19933395
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of Hypothalamic VGF in Energy Balance and Metabolic Adaption to Environmental Enrichment in Mice.
    Foglesong GD; Huang W; Liu X; Slater AM; Siu J; Yildiz V; Salton SR; Cao L
    Endocrinology; 2016 Mar; 157(3):983-96. PubMed ID: 26730934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The melanocortin system as a therapeutic treatment target for adiposity and adiposopathy.
    Bays H
    Drugs R D; 2006; 7(5):289-302. PubMed ID: 16922590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH.
    Anderson EJ; Çakir I; Carrington SJ; Cone RD; Ghamari-Langroudi M; Gillyard T; Gimenez LE; Litt MJ
    J Mol Endocrinol; 2016 May; 56(4):T157-74. PubMed ID: 26939593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in the development of melanocortin receptor selective ligands.
    Irani BG; Holder JR; Todorovic A; Wilczynski AM; Joseph CG; Wilson KR; Haskell-Luevano C
    Curr Pharm Des; 2004; 10(28):3443-79. PubMed ID: 15579046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of melanocortin receptor small molecule ligands.
    Todorovic A; Haskell-Luevano C
    Peptides; 2005 Oct; 26(10):2026-36. PubMed ID: 16051395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis.
    Gavini CK; Jones WC; Novak CM
    J Physiol; 2016 Sep; 594(18):5285-301. PubMed ID: 27126579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Targets for Drug Treatment of Obesity.
    Valsamakis G; Konstantakou P; Mastorakos G
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():585-605. PubMed ID: 28061687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The central melanocortin system and human obesity.
    Yang Y; Xu Y
    J Mol Cell Biol; 2020 Oct; 12(10):785-797. PubMed ID: 32976556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of central melanocortin signaling in eating disorders.
    Lu XY
    Psychopharmacol Bull; 2001; 35(4):45-65. PubMed ID: 12397856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central serotonin and melanocortin pathways regulating energy homeostasis.
    Heisler LK; Cowley MA; Kishi T; Tecott LH; Fan W; Low MJ; Smart JL; Rubinstein M; Tatro J; Zigman JM; Cone RD; Elmquist JK
    Ann N Y Acad Sci; 2003 Jun; 994():169-74. PubMed ID: 12851313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Energy homeostasis regulated by an adipocyte-derived hormone--mechanism of leptin resistance and role of hypothalamic melanocortin signaling].
    Masuzaki H; Tanaka T; Ebihara K; Hosoda K; Nakao K
    Nihon Rinsho; 2009 Feb; 67(2):287-96. PubMed ID: 19202901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding.
    Harrold JA; Widdowson PS; Williams G
    Diabetes; 1999 Feb; 48(2):267-71. PubMed ID: 10334300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New ligands for melanocortin receptors.
    Kaelin CB; Candille SI; Yu B; Jackson P; Thompson DA; Nix MA; Binkley J; Millhauser GL; Barsh GS
    Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S19-27. PubMed ID: 19136986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.